US surgeon recovers from Bundibugyo Ebola after treatment at Berlin’s Charité
A US surgeon infected with the Bundibugyo Ebola virus recovered after more than two weeks of care at Berlin’s Charité, and was cleared from quarantine on June 6, 2026, as the outbreak in the DRC grows.
US surgeon discharged after intensive treatment in Berlin
A 39-year-old US surgeon identified in media reports as Peter Stafford was declared in good health and released from quarantine by Charité hospital on June 6, 2026. Stafford was admitted to Charité on May 20, 2026, after tests confirmed infection with the Bundibugyo Ebola strain, the same virus driving the current outbreak in the Democratic Republic of the Congo. Hospital officials said the patient received intensive care and monitoring during his stay and described his recovery as a notable therapeutic success. The case drew attention because he fell ill while working in the DRC before the outbreak was officially declared on May 15, 2026.
Medical evacuation from Uganda and family quarantine protocols
Stafford was flown from Uganda to Berlin on a specially equipped aircraft under strict infection-control procedures on May 20, 2026. His wife and four children, who were asymptomatic but initially classified as high‑risk contacts, arrived in Berlin and were placed in a separate quarantine area of the same ward. Authorities said the family’s isolation restrictions were lifted on June 6, 2026, after medical evaluation and observation periods concluded without signs of infection. The transfer and separate containment reflect international protocols for handling highly infectious viral haemorrhagic fevers.
Treatment included experimental therapies but no approved Bundibugyo vaccine
Charité confirmed the patient received supportive care and experimental therapies that are currently being trialled for infections caused by Ebola-family viruses. While three candidate vaccines are being fast-tracked toward trials, there remains no licensed vaccine specifically approved for the Bundibugyo strain. Stafford publicly thanked hospital staff and acknowledged the disparity in access to advanced care, noting that many people in the DRC do not have similar treatment options. Leif Erik Sander, director of the hospital’s Department of Infectious Diseases and Intensive Care Medicine, called the recovery “a significant therapeutic success.”
DRC case count rises and WHO declares international emergency
Health authorities in the Democratic Republic of the Congo reported that the outbreak’s caseload rose to 488 confirmed and probable cases from a previously reported 452, with 86 deaths recorded. Uganda has confirmed 19 cases and two deaths connected to the cross-border spread. The World Health Organization has declared the situation an international public health emergency, and the US Centers for Disease Control and Prevention warned the outbreak could escalate to rival the 2014–2016 West Africa epidemic if containment measures fail. Public health agencies continue to emphasize rapid case identification, isolation, and contact tracing to interrupt transmission chains.
Cross-border controls, trade disruption and local response
Ugandan authorities have largely closed their western border with the DRC in an effort to reduce cross-border contagion, triggering frustration among traders who depend on border crossings for their livelihoods. Local health officials and international partners are scaling up surveillance in border districts while providing community outreach to inform residents about symptoms, safe burial practices, and when to seek care. Humanitarian and public health groups have warned that movement restrictions can have economic and social consequences, and they are calling for support measures to mitigate harm to affected communities. Observers say community engagement will be critical to secure cooperation for contact tracing and vaccination trials.
Global research push and next steps for containment
International researchers are accelerating plans for clinical trials of candidate vaccines and therapeutics that could target Bundibugyo and related Ebola viruses. Regulators and funders are coordinating expedited reviews to allow trials in affected areas while ensuring safety and ethical oversight. Meanwhile, WHO and national health ministries are urging governments to bolster laboratory capacity, stockpile personal protective equipment, and prioritize frontline health worker protection. Officials stress that early detection and rapid isolation remain the most effective tools to reduce transmission until licensed medical countermeasures are available.
The recovery of the US surgeon in Berlin highlights both the potential of specialized care and the stark inequities in health access faced by people in outbreak zones, underscoring the urgency of expanding treatment, testing and preventive measures in the DRC and neighbouring countries.
